gsk zantac news - Search News

GSK settles vast majority of Zantac claims

Hosted on MSN · 23h

GSK settles vast majority of Zantac claims for $2.2 billion

The British drugmaker reached a $2.2 billion settlement to resolve around 80,000 lawsuits over claims its Zantac heartburn remedy causes cancer

GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.

The Wall Street Journal on MSN · 23h

GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits

GSK agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine Zantac causes cancer.

The company also agreed to pay $70 million to settle a whistleblower lawsuit

GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac ...

GSK will pony up $2.2B to resolve 80K Zantac cases

The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.

15h

FTSE 100 Live 10 October: GSK shares rise on $2.2bn Zantac settlement, property firm gets £1.1bn bid

GSK’s $2.2 billion Zantac settlement today put its shares top of the FTSE 100, albeit still well short of their level before ...

16hon MSN

UK borrowing costs hit three-month high amid ‘buyers’ strike’ fears; GSK’s shares surge after $2.2bn Zantac settlement – business live

Yield on 10-year UK government debt hits highest since early July, while inflation has eased in the US. 15:39 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results